Opko Health (OPK) Research & Development (2010 - 2026)
Opko Health's (OPK) quarterly Research & Development came in at $33.2 million in Q2 2026, up 9.31% on a YoY basis from $30.3 million in Q2 2025, and up 13.59% quarter-over-quarter from $29.2 million in Q1 2026.
Powered by 
Analysis
Opko Health (OPK) Research & Development (2010 - 2026) Analysis & Trends
Opko Health (OPK) has reported Research & Development for 17 consecutive years, with $33.2 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Research & Development rose 9.31% year-over-year to $33.2 million; the trailing twelve-month figure through Jun 2026 stood at $125.2 million (down 31.2% YoY), and the FY2025 full-year result was $124.0 million, up 17.89% from the prior year.
- Research & Development advanced to $33.2 million in Q2 2026 per OPK's latest filing, from $29.2 million in the prior quarter.
- Across five years, Research & Development topped out at $74.8 million in Q3 2024 and bottomed at $17.3 million in Q2 2022.
- Historically, Research & Development has averaged $29.0 million across 5 years, with a median of $29.2 million in 2026.
- The sharpest annual moves came in 2024 and 2025: Research & Development jumped 284.82% in 2024, then slumped 59.78% in 2025.
- Over 5 years, Research & Development stood at $19.5 million in 2022, then decreased by 0.69% to $19.4 million in 2023, then jumped by 285.63% to $74.8 million in 2024, then plunged by 56.18% to $32.8 million in 2025, then gained by 1.2% to $33.2 million in 2026.
- According to Business Quant data, Research & Development over the past three periods registered $33.2 million, $29.2 million, and $32.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn | 2.81 Bn |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn | 2.96 Bn |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn | -2.60 Bn |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - | 394.92 Mn |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn | 612.28 Mn |
| 10 | Opko Health | 1.25 Bn | 945.61 Mn | 80.02 Mn | 33.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 33.17 Mn |
| Mar 31, 2026 | 29.20 Mn |
| Dec 31, 2025 | 32.77 Mn |
| Sep 30, 2025 | 30.08 Mn |
| Jun 30, 2025 | 30.34 Mn |
| Mar 31, 2025 | 30.84 Mn |
| Sep 30, 2024 | 74.79 Mn |
| Jun 30, 2024 | 46.02 Mn |
| Mar 31, 2024 | 21.94 Mn |
| Dec 31, 2023 | 19.39 Mn |
| Sep 30, 2023 | 19.44 Mn |
| Jun 30, 2023 | 18.16 Mn |
| Mar 31, 2023 | 32.61 Mn |
| Dec 31, 2022 | 19.53 Mn |
| Sep 30, 2022 | 18.79 Mn |
| Jun 30, 2022 | 17.25 Mn |
| Mar 31, 2022 | 18.31 Mn |
| Dec 31, 2021 | 21.01 Mn |
| Sep 30, 2021 | 18.31 Mn |
| Jun 30, 2021 | 18.22 Mn |
API Access
Opko Health Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=OPK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "OPK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=OPK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();